Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety, Tolerability, Pharmacokinetics, and Efficacy of GS-4224 in Participants With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04049617
Recruitment Status : Terminated (Gilead decision to terminate)
First Posted : August 8, 2019
Last Update Posted : April 26, 2021
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 30, 2021
Actual Study Completion Date : March 30, 2021